Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Heatmap
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
NSRX
#4659
Nasus Pharma Ltd.
2.280
0
USD
+1.33%
Secteur:
Base:
USD
Devise de Profit:
USD
Range quotidien
Range Annuel
Changement quotidien
+1.33%
Changement Mensuel
-38.88%
Evolution sur 6 mois
-70.62%
Changement Annuel
-71.75%
Clôture Précédente
2.250
0
Open
2.280
0
Bid
Ask
Low
2.280
0
High
2.280
0
Volume
1
Marchés
Actions des Marchés US
NSRX
Open full chart
Financials
Overview
Relevé
Statistics
Quarterly
Annual
Value
2025
TTM
Key stats
Total common shares outstanding
9.02 M
—
Valuation ratios
Enterprise value
81.37 M
—
Price to earnings ratio
-12.71
—
Price to sales ratio
0.06
—
Price to cash flow ratio
-14.9
—
Price to book ratio
26.48
—
Enterprise value to EBITDA ratio
—
—
Profitability ratios
Return on assets %
-1.17
—
Return on equity %
-2.12
—
Return on invested capital %
—
—
Gross margin %
100
—
Operating margin %
-0.4
—
EBITDA margin %
—
—
Net margin %
-0.47
—
Liquidity ratios
Quick ratio
—
—
Current ratio
2.24
—
Inventory turnover
—
—
Asset turnover
246.8
—
Solvency ratios
Debt to assets ratio
0.02
—
Debt to equity ratio
0.04
—
Long term debt to total assets ratio
0
—
Long term debt to total equity ratio
0
—
Per share metrics
Operating cash flow per share
-0.61
—
EBIT per share
153.57
—
EBITDA per share
—
—
Total debt per share
0.01
—
Cash per share
0.15
—
Net current asset value per share
0.61
—
Tangible book value per share
0.35
—
Working capital per share
0.34
—
Book value per share
0.35
—